* Revvity Inc RVTY.N reported quarterly adjusted earnings
of
$1.28 per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $1.18. The mean expectation of nineteen analysts for the
quarter was for earnings of $1.13 per share. Wall Street
expected results to range from $1.12 to $1.15 per share.
* Revenue rose 2% to $684.05 million from a year ago;
analysts
expected $679.65 million.
* Revvity Inc's reported EPS for the quarter was 77 cents.
* The company reported quarterly net income of $94.37
million.
* Revvity Inc shares had fallen by 5.3% this quarter and
gained 10.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, two analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 9
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Revvity Inc is
$137.00
This summary was machine generated from LSEG data November 4 at
03:19 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 1.13 1.28 Beat
Jun. 30 2024 1.12 1.22 Beat
Mar. 31 2024 0.93 0.98 Beat
Dec. 31 2023 1.16 1.25 Beat